Literature DB >> 11040554

Strategies for implementing a guided imagery program to enhance patient experience.

D L Tusek1, R E Cwynar.   

Abstract

The patient in acute care settings can have severe emotional and physical stresses that are also experienced by family and significant others. The experience in a hospital has often been described as overwhelming; it can evoke feelings of fear, anger, helplessness, and isolation. Guided imagery, one of the most well-studied complementary therapies, is used increasingly to improve patients' experiences and healthcare outcomes. More and more, patients are relying on the use of guided imagery to provide a significant source of strength, support, and courage as they prepare for a procedure or manage the stresses of a hospital stay. This article provides a brief review of the research base for guided imagery and broad indications for its use. It describes key elements of the therapy and outlines steps to implement a program of guided imagery that can be used in variety of settings.

Entities:  

Mesh:

Year:  2000        PMID: 11040554     DOI: 10.1097/00044067-200002000-00009

Source DB:  PubMed          Journal:  AACN Clin Issues        ISSN: 1079-0713


  3 in total

1.  Managing pain and fatigue in people with spinal cord injury: a randomized controlled trial feasibility study examining the efficacy of massage therapy.

Authors:  J Lovas; Y Tran; J Middleton; R Bartrop; N Moore; A Craig
Journal:  Spinal Cord       Date:  2016-11-29       Impact factor: 2.772

2.  The Feasibility and Effectiveness of Online Guided Imagery Training for Health Professionals.

Authors:  Nisha Rao; Kathi J Kemper
Journal:  J Evid Based Complementary Altern Med       Date:  2016-02-14

3.  Guided Imagery for Total Knee Replacement: A Randomized, Placebo-Controlled Pilot Study.

Authors:  Ann F Jacobson; Wendy A Umberger; Patrick A Palmieri; Thomas S Alexander; Rodney P Myerscough; Claire B Draucker; Susann Steudte-Schmiedgen; Clemens Kirschbaum
Journal:  J Altern Complement Med       Date:  2016-05-23       Impact factor: 2.579

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.